Addiction is one of the most intensely studied conditions in modern medicine, yet even with high‑resolution brain scans and genetic tools, scientists still cannot fully explain why some people get ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

Researchers from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) report that the gene, CHRNA3, acts as a key regulator of alcohol sensitivity. Published in ...

A 2024 U.S. national survey reported that 11.8% of males and 7.6% of females ages 12 and older met the criteria for Alcohol Use Disorder (AUD) in 2023, meaning they could not stop or control alcohol ...

Scientists discovered that alcohol activates a sugar-producing pathway in the body, creating fructose that may reinforce addictive drinking. The enzyme responsible, KHK, appears to drive both alcohol ...

Scientists say they've uncovered striking new evidence of how alcohol addiction impacts the brain's learning systems—and how those systems may slowly adapt during recovery—in a new study published in ...

What’s the most addictive drug? Newly published research indicates that when focusing on persistent drug memory, craving, and addiction, the most addictive illegal drug is cocaine. In contrast, the ...

There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...

Addiction is one of the most common and consequential chronic medical conditions in the United States. Nationwide, more than 46 million people met the criteria for a substance abuse disorder as of ...

Alcohol is a toxic depressant that affects the brain, body, mental health, judgment, and behaviour. Learn the dangers of ...